P W Jeroen Maljaars

9PUBLICATIONS
12CO-AUTHORS
Behavioural epidemiologyImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Food properties (incl. characteristics and health benefits)Pharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 21, 2023
Frailty and Inflammatory Bowel Disease: A Scoping Review of Current Evidence.

Anne Fons, Kees Kalisvaart, Jeroen Maljaars

|Jul 23, 2022
Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases.

Adriaan Volkers, Tessa Straatmijer, Marjolijn Duijvestein

|Mar 12, 2021
Editorial: opioids in inflammatory bowel disease-primum non nocere.

Mike van der Have, Jeroen Maljaars

|Oct 21, 2020
Editorial: is age just a number when it comes to treatment of inflammatory bowel disease? Authors' reply.

Vera E R Asscher, Vince B C Biemans, Frank Hoentjen

Pageof 2